This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Herbalife Hedges: Dan Loeb Owns Bill Ackman

It's well done, and at the caliber one would expect out of massively successful network marketing company. The video doesn't leave a lot of room to take shots at their claims. I understand it's all about marketing, but I have to give them credit, disinterested parties will likely view the company in a positive light after watching. Not everyone will be as impressed with the message as I was.

According to The Wall Street Journal, Hedge fund manager Whitney Tilson's T2 Partners is shorted Herbalife in part based on Ackman's presentation. "Pershing Square's analysis of Herbalife is the most remarkable piece of investment analysis I have ever seen. Simply astonishing" Tilson said.

I am not sure that Tilson and I watched and read the same presentation because when I was finished I had the opposite reaction. In Will Herbalife End Up a Penny Stock? I wrote "I read the presentation and listened to Ackman state his case. I wasn't convinced and finished with the impression that I just read a "hit piece" relying more on emotion than logic" and "For example, the percentage of insurance salespeople who make more than $100,000 a year is probably similar to the percentage of successful Herbalife representatives."

I looked at the numbers, and evidence, and entered a bullish position. The option premium as a result of the incredible expansion in implied volatility sealed the deal and in less than a week later I exited the majority of my position. When the January options expire I expect I will be out the rest of the position.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
HLF $52.03 0.60%
AAPL $130.28 -1.14%
FB $79.19 -1.19%
GOOG $532.11 -1.42%
TSLA $250.80 -0.26%

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs